MSH Awarded Five-Year Cooperative Agreement for Strengthening Pharmaceutical Systems

CAMBRIDGE, MA (AUGUST 1, 2007)—Management Sciences for Health (MSH) has been awarded by the US Agency for International Development (USAID) a five-year, $147.5-million Leader with Associates Cooperative Agreement, Strengthening Pharmaceutical Systems (SPS). The new program is a follow-on to the current Rational Pharmaceutical Management (RPM) Plus Program, which will continue through September 2008.

New funding sources in the international aid community are making unprecedented sums of money available to procure medicines for deadly diseases in developing countries, but inadequate pharmaceutical supply systems and the worsening human resource crisis threaten the success of these efforts. SPS will work to address these challenges.

By adapting its work to each country’s disease priorities, system gaps, resources, and political environment, SPS will help institutions and individuals in developing countries build capacity to improve their citizens’ access to lifesaving, essential medicines of assured quality. The program will focus on four key results:

  1. Improved governance in the pharmaceutical sector;
  2. Strengthened pharmaceutical management systems to support public health services;
  3. Containment of the emergence and spread of antimicrobial resistance;
  4. Expanded access to and improved use of essential medicines.

To help meet the goals of these key result areas, the SPS Program will build on the successes of RPM Plus while expanding the range of technical areas ,to include financing, pharmacovigilance, pharmaceutical care, integration of new health technologies, and increased use of the private sector. MSH will accomplish this enhanced program of activities by collaborating with a number of new partner organizations.

The SPS core partner team includes BroadReach Healthcare, the Ecumenical Pharmaceutical Network, the Lewin Group, LMI Government Consulting, the University of Washington Department of Global Health, and the World Health Organization (WHO) Collaborating Center in Pharmaceutical Policy at Harvard and Boston universities.

In addition to the core team, MSH is joined by a select group of organizations that will serve as specialized resources for SPS. Included are the African Medical and Research Foundation (AMREF), American Society of Health-System Pharmacists (ASHP), Euro Health Group, Infectious Disease Institute (IDI) at Makerere University, Joint Commission International (JCI), and London School of Hygiene and Tropical Medicine.

As we work toward the overall goal of SPS, the SPS team will strive to advance the science and “art” of strengthening pharmaceutical management systems. The SPS Program provides a great opportunity for MSH and USAID to continue supporting developing countries in their quest to increase access to essential medicines and facilitate the scale up of vital treatment programs.

Contact: Marie-Reine Maroun, Communications Associate Center for Pharmaceutical Management 703-310-3428